McCann Health Engagement
As a media agency exclusively focused on healthcare, McCann Health Engagement has deep knowledge and vast experience planning and buying in the pharmaceutical industry specific to HCP and DTC on a global scale. We have experience working on almost every therapeutic category within the healthcare and pharmaceutical landscape.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
CMI Media Group
CMI Media Group, a WPP company, is a full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and…
Four Agency Worldwide
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…
Havas Lynx
We are the Havas Lynx. Devoted to fresh thinking. Changing the way the world does healthcare communications for the better. Great talent. Great ideas. Great outcomes.
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
Company Details
Latest Content from PMHub
Taking a hybrid qualitative-quantitative approach to research
White Papers and Resources | July 5, 2017 | Inizio
Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.Watch the video: https://www.researchpartnership.com/news/2017/06/video-taking-a-hybrid-qualitative-quantitative-appr...
20th anniversary celebrations
White Papers and Resources | July 5, 2017 | Inizio
We recently celebrated our 20th year anniversary with parties for our employees across the globe.Find out more and view the photos https://www.researchpartnership.com/news/2017/06/20th-anniversary-party-photos/
Pharma CI Asia Conference & Exhibition 2017
White Papers and Resources | July 5, 2017 | Inizio
13-14 July 2017, Singapore
Director Richard Head is joint winner of the 2017 EphMRA President’s Award
White Papers and Resources | July 5, 2017 | Inizio
We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research
Forever Angels founder is awarded an MBE
White Papers and Resources | July 5, 2017 | Inizio
We are delighted to announce that Forever Angels founder Amy Hathaway has been awarded an MBE in this year’s Queen’s Birthday Honours list for providing interim and community care to...
Research Partnership’s Singapore team relocates to new office
White Papers and Resources | July 5, 2017 | Inizio
We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.
Nutrition Market in Brazil: Growth Against the Odds
White Papers and Resources | July 5, 2017 | Inizio
Published in eyeforpharma June 2017 by Marc Yates
Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report
White Papers and Resources | July 5, 2017 | Inizio
Living with Ulcerative Colitis (UC) is a study conducted amongst 100 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...
Research Partnership is celebrating 20 years in business
White Papers and Resources | July 5, 2017 | Inizio
Watch our short video to see how we have grown. Please note the video comes with some fun, themed music. https://www.researchpartnership.com/news/2017/06/research-partnership-is-celebrating-20-years-in-bus...
Therapy Watch expands oncology and IBD portfolios
White Papers and Resources | July 5, 2017 | Inizio
This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in...